Accurate urine specimens are essential to the accurate diagnoses and treatment of myriad routine and more serious conditions.
Peezy Midstream is the world’s first technology to deliver integrity to urine based medicine and can help tackle huge health inequalities across the USA.
Stats and data relating to urine collection in the USA:
- 277m urines sent for analysis annually
- 20% is the average contamination rate
- 55.2m failed analyses at $13 each
The annual cost of unreliable specimens to US health providers and insurers is an estimated $517m, 46% of which is not reimbursed.
Evidence from Loyola Chicago University Stritch School of Medicine confirms that Peezy Midstream delivers a superior quality midstream urine specimen and can be downloaded here.
Failure to diagnose and treat will lead to chronic conditions that are far more difficult to manage for healthcare provider and patient alike.